Boston Scientific (BSX) Tops Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/11/2026
- Wall Street ends down as US-Iran peace optimism fades
- S&P 500 EPS growth above 20% is rare. Why 2027 may be at risk
- Goldman Sachs warns AI investment may be crowding out other business spending
- Why Wednesday's inflation print could provide the next dovish catalyst
- Tesla needs Robotaxi flywheel proof to boost investor conviction: Morgan Stanley
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
Boston Scientific (BSX) PT Raised to $26 at Oppenheimer Following Solid 4Q
February 3, 2017 9:47 AM ESTOppenheimer raised its price target on Boston Scientific (NYSE: BSX) to $26.00 (from $25.00) while maintaining a Perform rating following the company's 4Q report.
Analyst Steven Lichtman commented, "BSX delivered strong, broad-based sales growth in 4Q16 and continued solid operating margin expansion. Sales in the quarter... More
